China Kangtai Cactus Bio-Tech Inc (fka CKGT)

[StevenRisk]

While I believe Gary and Glen could/ would do a better job that alone is not the problem.

The company has been communicating with shareholders on a very regular basis when news is newsworthy thus not a bunch of fluff PR's.

The problems that come to mind is:

1) slow product release as it takes 2-3 years after patent

2) cactus supply which IMO is the reason for #1 as they want to be 100% capable of producing the launched product with no shortages.

3) Most investors are U.S. and still have not grasped the fact that cactus is a healthy product with l-term benfets. Once this is confirmed with some institutional support this too, changes.

4) No updates or mention of an uplisting from management. This alone doubles the price immediately.

5) No mention of net income for 2010 in the guidance. If you want to get an indication of this look no further than the past result as that usually is an indicator. Patience is needed but let it be known this story is unfolding very positively.

There are times when it appears as though we are talking to ourselves on this board. Hwever this to will change. While many have been following this stock, most of these investors have very small holdings. Personally my shares are over six figures and I am a very strong believer and will stick with my $6-8 yearend price.